Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

TENOFOVIR ALAFENAMIDE

TENOFOVIR ALAFENAMIDE FUMARATE

Standard Dose
EQ 25MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TENOFOVIR ALAFENAMIDE is listed in Drugs@FDA under application 214226 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TENOFOVIR ALAFENAMIDE FUMARATE Form and strength TABLET;ORAL - EQ 25MG BASE Sponsor LUPIN LTD Submission history Latest submission status date: 2023-03-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview TENOFOVIR ALAFENAMIDE is listed in Drugs@FDA under application 214226 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TENOFOVIR ALAFENAMIDE FUMARATE Form and strength TABLET;ORAL - EQ 25MG BASE Sponsor LUPIN LTD Submission history Latest submission status date: 2023-03-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.